IP Library Granted Patent US 10,072,234
Granted Patent B2
US 10,072,234 · App. 14/095,477 · Granted Sep 11, 2018

Fragrance compositions

Inventors: John Martin Behan (Kent, GB); Briony Care (Kent, GB); Anne Churchill (Kent, GB); Michael Gordon Evans (Kent, GB); Keith Douglas Perring (Kent, GB); Alan Forbes Provan (Kent, GB)
Assignee: Givaudan S.A.
C11B9/02C11B9/00C11B9/008C11B9/0015C11B9/0019C11B9/0034C11B9/0061C11B9/0069C11B9/0073C11B9/0092
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,072,234
App. No.
14/095,477
Granted
Sep 11, 2018
Kind
B2
Abstract

A fragrance composition and use thereof by inhalation to promote activated, pleasant moods. The fragrance composition comprises at least 75% by weight of perfume materials including at least 10% by weight of at least three specific materials from a group identified as Group IMP and optionally up to 90% of specific materials selected from groups identified as HMR, HMI, HMP, RMP and GEN, the amounts of materials from said Groups falling within specified relationships.

Claims (37)

1. A fragrance composition comprising at least 40 perfume ingredients present in an amount of at least 75% by weight, wherein the ingredients are selected from the following groups:

A) at least 15% by weight in total of at least three ingredients are selected from Group ‘IMP’, wherein Group ‘IMP’ comprises: allyl amyl glycolate; benzyl salicylate; bergamot oil; coriander oil; cyclamen aldehyde; 1-(2,6,10-trimethylcyclododeca-2,5,9-trien-1-yl)ethanone; prop-2-enyl (cyclohexyloxy)acetate; Damascenia 185 SAE; 2,4-dimethylheptan-1-ol; fir balsam; fir needle oil; 3-(4-ethylphenyl)-2,2-dimethylpropanal; ginger oil; guaiacwood; linalyl acetate; litsea cubeba oil; methyl 2,4-dihydroxy-3,6-dimethylbenzoate; nutmeg oil; olibanum oil; orange flower oil; Ozonal AB 7203C; patchouli oil; rose oxide; rosemary oil; sage clary oil; spearmint oil; Tamarine AB 8212E; and tarragon oil;

B) optionally up to 90% by weight of the ingredients are selected from the following groups:

Group ‘HMR’ comprising:

allyl ionone; benzyl acetate; cis-jasmone; citronellol; ethyl linalol; ethylene brassylate; 4-methyl-2-(2-methylpropyl)tetrahydro-2H-pyran-4-ol; geraniol; geranium oil; iso-eugenol; lemon oil; 3-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde; 4-(4-hydroxy-4-methylpentyl)cyclohex-3-ene-1-carbaldehyde; alpha-iso-methyl ionone; 3-methylcyclopentadec-2-en-1-one; cyclopentadecanone; cyclohexadecanolide; and gamma-undecalactone;

Group ‘HMI’ comprising:

1-{[2-(1,1-dimethylethyl)cyclohexyl]oxy}butan-2-ol; 3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-{b}]furan; alpha-damascone; dihydromyrcenol; eugenol; 3-(1,3-benzodioxol-5-yl)-2-methylpropanal; 2,4-dimethylcyclohex-3-ene-1-carbaldehyde; mandarin oil; orange oil; and 2-(1,1-dimethylethyl)cyclohexyl acetate;

Group ‘HMP’ comprising:

1-(2,6,6,8-tetramethyltricyclo [5.3.1.0{1,5}]undec-8-en-9-yl)ethanone; allyl cyclohexylpropionate; allyl heptanoate; Apple Oliffac S pcmf; 7-methyl-2H-1, 5-benzodioxepin-3(4H)-one; cassis base; cis-3-hexenyl salicylate; damascenone; gamma-decalactone; ethyl acetoacetate; ethyl maltol; ethyl methyl phenylglycidate; hexyl acetate; (3E)-4-methyldec-3-en-5-ol; 2,5,5-trimethyl-6,6-bis(methyloxy)hex-2-ene; 4-(4-hydroxyphenyl)butan-2-one; styrallyl acetate; 2,2,5-trimethyl-5-pentylcyclopentanone; and ylang oil;

Group ‘RMP’ comprising:

anisic aldehyde; (2Z)-2-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl)but-2-en-1-ol; benzoin siam resinoid; ethyl vanillin; oxacyclohexadec-12(13)-en-2-one; hexyl salicylate; hydroxycitronellal; jasmin oil; 3-methyl-5-phenylpentan-1-ol; 2-(phenyloxy)ethyl 2-methylpropanoate; alpha-terpineol; and vanillin; and

Group ‘GEN’ comprising:

cyclopentadecanolide; hexyl cinnamic aldehyde; ionone beta; isobornyl cyclohexanol; 1-(2,3,8,8-tetramethyl-1,2,3,4,5,6,7(8),8(8a)-octahydronaphthalen-2-yl)ethanone; 3-[4-(1,1-dimethylethyl)phenyl]-2-methylpropanal; linalol; methyl dihydrojasmonate; and 2-phenylethanol;

provided the following conditions (a) through (e) are met:

(a) IMPs >=HMPs +HMRs;

(b) IMPs +HMIs +GENs >=70%;

(c) (IMP +HMI)/(IMP +HMI +RMP +HMR)>=0.7;

(d) IMPs/(HMPs+RMPs+IMPs) >=0.5; and

(e) IMPs/[(HMPs+RMPs+IMPs) +(100-TOTAL)] >=0.3,

wherein ‘IMPs’ indicates the sum of the percentages of the ingredients within Group IMP, and similarly for the remaining groups, the symbol ‘>=’ indicates ‘at least equal to’, and ‘TOTAL’ is the sum of HMPs, HMRs, HMIs, IMPs, RMPs and GENs, provided also that solvents scoring less than 80on an odour index scale based on a comparison with the odour intensity of a control sample of a 10% solution of benzyl acetate in dipropylene glycol, which corresponds to an index of 100 are excluded from the calculation of these sums.

2. A fragrance composition according to claim 1 , where at least 80% by weight of the ingredients are from the total of Groups IMP, HMI and GEN.

3. A fragrance composition according to claim 1 , wherein the ratio of IMPs/(HMPs +RMPs +IMPs) is at least 0.6.

4. A fragrance composition according to claim 1 , where at least five of the ingredients are from Group IMP.

5. A fragrance composition according to claim 4 , where at least eight of the ingredients are from Group IMP.

6. A fragrance composition according to claim 1 , where at least 90% by weight of the ingredients are from the total of Groups IMP, HMI and GEN.

7. A consumer composition comprising a fragrance composition according to claim 1 .

8. A method of providing activated, pleasant moods through inhalation of an effective amount of a fragrance composition according to claim 1 .

9. A process of dispensing a fragrance composition according to claim 1 in an amount and for a time sufficient to provide effective vaporous emission for inhalation by a subject.

10. A fragrance composition according to claim 1 , comprising at least two ingredients from the GEN group.

11. A fragrance composition according to claim 10 , wherein the at least two ingredients are linalol and 3-[4-(1,1-dimethylethyl)phenyl]-2-methylpropanal.

12. A fragrance composition according to claim 1 , comprising at least one ingredient from the HMI group.

13. A fragrance composition according to claim 1 , wherein one of the at least three ingredients present from the IMP group is methyl 2,4-dihydroxy-3,6-dimethylbenzoate.

14. A fragrance composition according to claim 1 , wherein one of the at least three ingredients present from the IMP group is linalyl acetate.

15. A fragrance composition according to claim 1 , comprising at least one ingredient from the RMP group.

16. A fragrance composition according to claim 15 , wherein the at least one ingredient from the RMP group is alpha-terpineol.

17. A fragrance composition according to claim 1 , comprising at least two ingredients from the GEN group and at least one ingredient from the HMI group.

18. A fragrance composition according to claim 17 , further comprising at least one ingredient from the RMP group.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2015
From: GIVAUDAN NEDERLAND SERVICES B.V.
To: GIVAUDAN S.A.
Reel/Frame 037206/0918 →
CHANGE OF NAME Recorded Apr 1, 2014
From: QUEST INTERNATIONAL SERVICES B.V.
To: GIVAUDAN NEDERLAND SERVICES B.V.
Reel/Frame 032588/0548 →
Priority Claims (1)
GB 0621023.1 · Oct 23, 2006 · national
Continuity (3)
Continuation 12986687 · Jan 7, 2011
Division 11604256 · Nov 27, 2006
Related Publication 20140194338A1 · Jul 10, 2014